Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 0 | 0 | 0 | 60 | 1,270 |
| Gross Profit | N/A | N/A | N/A | 60 | 1,310 |
| Operating Expenses | 4,734 | 3,424 | 0 | 3,310 | 2,910 |
| Operating Income | -4,734 | -3,424 | N/A | -3,250 | -1,640 |
| Other Income | 70 | 68 | 0 | 180 | 170 |
| Pre-tax Income | -4,664 | -3,356 | 0 | -3,070 | -1,470 |
| Income Tax | 13 | N/A | N/A | 0 | 0 |
| Net Income Continuous | -4,677 | -3,356 | N/A | -3,070 | -1,470 |
| Net Income | $-4,677 | $-3,356 | $N/A | $-3,070 | $-1,470 |
| EPS Basic Total Ops | -0.73 | -0.50 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.74 | -0.53 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.73 | -0.50 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.74 | -0.53 | N/A | N/A | N/A |
| EBITDA(a) | $-4,699 | $-3,391 | $N/A | $-3,250 | $-1,600 |